Biomakers Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
77
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8M
- Investors
-
12
Biomakers General Information
Description
Developer of a centralized precision oncology platform designed to expand access to quality cancer care while generating the globally relevant data and insights needed to advance cancer drug and diagnostic development. The company offers an integrated ecosystem that connects genomic testing, clinical data, AI and an extensive biobank of tumor samples, enabling customers to access personalized cancer treatments, make data-driven clinical decisions, accelerate R&D and optimize clinical trial matching.
Contact Information
Website
www.biomakers.ioCorporate Office
- 39 Mesa Street
- Suite 207
- San Francisco, CA 94129
- United States
Corporate Office
- 39 Mesa Street
- Suite 207
- San Francisco, CA 94129
- United States
Biomakers Timeline
Biomakers Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 15-Dec-2025 | $8M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Later Stage VC (Series A) | 15-Mar-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Biomakers Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Biomakers Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biomakers Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biomakers Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Oncology Ventures | Venture Capital | Minority | ||
| Sky High VC | Venture Capital | Minority | ||
| Sonen Capital | Impact Investing | Minority | ||
| Venturance Alternative Assets | Asset Manager | Minority | ||
| Covance | Corporation | Minority |
Biomakers FAQs
-
When was Biomakers founded?
Biomakers was founded in 2014.
-
Where is Biomakers headquartered?
Biomakers is headquartered in San Francisco, CA.
-
What is the size of Biomakers?
Biomakers has 77 total employees.
-
What industry is Biomakers in?
Biomakers’s primary industry is Discovery Tools (Healthcare).
-
Is Biomakers a private or public company?
Biomakers is a Private company.
-
What is Biomakers’s current revenue?
The current revenue for Biomakers is .
-
How much funding has Biomakers raised over time?
Biomakers has raised $20M.
-
Who are Biomakers’s investors?
Oncology Ventures, Sky High VC, Sonen Capital, Venturance Alternative Assets, and Covance are 5 of 12 investors who have invested in Biomakers.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
